New York, NY -- (SBWIRE) -- 10/07/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Arca Biopharma Inc (NASDAQ:ABIO) , Bona Film Group Ltd (ADR) (NASDAQ:BONA), Apricus Biosciences Inc (NASDAQ:APRI) , Phoenix New Media Ltd ADR (NYSE:FENG)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Phoenix New Media Ltd ADR (NYSE:FENG) rose 4.57 percent to $12.82 today, on traded volume of 986,421 shares. The media company recently announced that it has entered into an agreement with China Unicom to offer a ‘Wo+ifeng’ mobile video data package, through its ifeng's mobile video app, to 3G customers of China Unicom. FENG stock has a 52-week range of $2.88 to $13.00. The company has a market capitalization of $987.48 million and P/E ratio of 39.40.
What was the Moving Force behind FENG's Bullish Run? Read This Research Report on FENG
Apricus Biosciences Inc (NASDAQ:APRI) shares are moving up in the current trading session, after the pharmaceutical company revealed that Federal Institute for Drugs and Medical Devices of Germany has given national phase permission to Vitaros, which is used to treat people suffering from erectile dysfunction. APRI stock has a 52-week range of $1.87 to $3.49. The company has a market capitalization of $87.28.
Will APRI Continue To Move Higher? Find Out Here
Bona Film Group Ltd (ADR) (NASDAQ:BONA) jumped 15.32 percent to $6.55 today, on traded volume of 1.15 million shares. The 52-week range of the stock is $3.58 to $6.99. BONA shares have been showing an upward trend for the past few weeks. The stock climbed nearly 44 percent in the last one month and that has brought the film distributor under the attention of investors.
What BONA’s Charts Are Signaling for Traders? Find Out Here
Arca Biopharma Inc (NASDAQ:ABIO) rose 5.52 percent to $1.72 today, on traded volume of 1.18 million shares. The 52-week range of the stock is $1.13 to $5.93. ABIO is a biopharmaceutical firm focused on developing genetically-targeted treatments for cardiovascular disorders and heart failure. The company has a market capitalization of $18.84 million.
Where is ABIO Headed Exactly? Find out in This Trend Analysis Reports
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)